Search Results - Yuhong She
- Showing 1 - 4 results of 4
-
1
Pulsatile Administration of the Epidermal Growth Factor Receptor Inhibitor Gefitinib Is Significantly More Effective than Continuous Dosing for Sensitizing Tumors to Paclitaxel by David B. Solit, Yuhong She, Jose Lobo, Mark G. Kris, Howard I. Scher, Neal Rosen, Frank Sirotnak
Published 2005Artigo -
2
BRAF mutation predicts sensitivity to MEK inhibition by David B. Solit, Levi A. Garraway, Christine A. Pratilas, Ayana Sawai, Gad Getz, Andrea Basso, Qing Ye, Jose Lobo, Yuhong She, Iman Osman, Todd R. Golub, Judith S. Sebolt‐Leopold, William R. Sellers, Neal Rosen
Published 2005Artigo -
3
Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics by Mona D. Lee, Yuhong She, Michael J. Soskis, Christopher P. Borella, Jeffrey R. Gardner, Paula A. Hayes, Benzon M. Dy, Mark Heaney, Mark R. Philips, William G. Bornmann, Francis M. Sirotnak, David A. Scheinberg
Published 2004Artigo -
4
Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics by Mona D. Lee, Yuhong She, Michael J. Soskis, Christopher P. Borella, Jeffrey R. Gardner, Paula A. Hayes, Benzon M. Dy, Mark Heaney, Mark R. Philips, William G. Bornmann, Francis M. Sirotnak, David A. Scheinberg
Published 2004Artigo
Search Tools:
Related Subjects
Cancer
Biology
Genetics
Biochemistry
Cancer cell
Cell growth
Medicine
Mitochondrion
Peptide
Peptidomimetic
Protein biosynthesis
Antibiotics
Breast cancer
Cancer research
Cell culture
Chemotherapy
Dosing
Enzyme
Epidermal growth factor receptor
Gefitinib
Gene
Internal medicine
Kinase
Lung cancer
MAPK/ERK pathway
MEK inhibitor
Melanoma
Mutation
Oncology
Paclitaxel